Please provide your email address to receive an email when new articles are posted on . Rapid eGFR decline occurred in 23% of patients on high-intensity exercise. Meanwhile, rapid eGFR decline ...
A new study published in the Journal American Medical Association showed that patients with an Cystatin C based estimated ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Results showed highest risks for CVD for low eGFR and ...
Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results